• News
  • Drug makers must address access to antibiotic...
News - published on 09 Jun 2022

Drug makers must address access to antibiotics to help slow the superbug threat

New report sets out six case studies of drug makers that are increasing local access to antibiotics and antifungals, including through technology transfers and partnerships. People in low- and middle-income countries cannot get the antibiotics and antifungal medicines they need. This is fuelling the spread of drug resistance.

Explore further

Get in touch

Back to top |